International Consolidated Airlines Group SA
Change company Symbol lookup
Select an option...
ICAGY International Consolidated Airlines Group SA
$NQUSS451020JPYT Nasdaq US Small Cap Food Producers T
LULU Lululemon Athletica Inc
AICAF Air China Ltd
OBMP OncBioMune Pharmaceuticals Inc
AVNW Aviat Networks Inc
AMPY Amplify Energy Corp
JEPI JPMorgan Equity Premium Income ETF
ABBV Abbvie Inc

Industrials : Airlines | Large Cap Value
Based in United Kingdom
Company profile

International Consolidated Airlines Group, S.A. is an airline company that holds the interests in airline and ancillary operations. Its segments include British Airways, Iberia, Vueling, Aer Lingus and Other Group companies. It combines the airlines in the United Kingdom, Spain and Ireland. It has approximately 573 aircrafts to over 268 destinations. The Company operates various aircraft fleet services, including Airbus A318, Airbus A319, Airbus A340-600, Boeing 787-800, Embraer E190 and Boeing 777-200, among others. The Company, through its subsidiaries, is engaged in providing airline marketing, airline operations, insurance, aircraft maintenance, storage and custody services, air freight operations and cargo transport services. The Company offers its services in cities, including London, Madrid, Barcelona, Rome and Dublin. The Company's brands include British Airways, Iberia, LEVEL, Vueling, Aer Lingus, IAG Cargo and Avios.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
Day's Change
0.0401 (0.70%)
B/A Size
Day's High
Day's Low

10-day average volume:

Media Alert For 2021 Global Scientific Summit On COVID-19

9:01 am ET April 8, 2021 (PR Newswire) Print
WHEN:         Thursday, April 15, 2021
              10 a.m. - 1:30 p.m. EDT | 2 p.m. - 5:30 p.m. GMT | Virtual video event
WHERE:        To register for the event, click here:
              You will receive an email with a webcast link prior to the start of the event.
              Attendees are invited to submit questions for panelists prior to the event at
WHAT:         The 2021 Global Scientific Summit on COVID-19 is being hosted by Carnival Corporation and WTTC, as well as supporting sponsors Hilton Worldwide Holdings and the U.S. Travel Association. The virtual event will explore the most up-to-date science on COVID-19 to inform practical approaches and best practices for moving beyond the pandemic.
              The event will focus on the most up-to-date science amassed from the past year of studying COVID-19, including how best to address the many ongoing questions about how the virus will affect society, travel and day-to-day activities moving forward. The Summit will feature world-renowned medical, epidemiological and public health experts to explore and share recent findings and daily practices to curb the spread of COVID-19 in a post-pandemic future.
              Panels will include fact-based discussions sharing the latest insights on epidemiology, screening, testing and tracing, therapeutics, vaccines, practical prevention and mitigation practices and more, including:
              (EQNX::save_"-- ")The Science of COVID-19:  Epidemiology; Transmission; Testing.
              (EQNX::save_"-- ")Treatment & Prevention:  Masks, Surfaces and Physical Distancing; Isolation and Quarantine; Vaccines; Therapeutics.
              (EQNX::save_"-- ")Life in a World with COVID-19:  Practicality; Adapting; Risk Mitigation.
              The event is designed for the general public, and it is free to attend all or parts of the discussion. Registration is now open at
WHO:          The virtual Summit is hosted by World Travel & Tourism Council (WTTC), which represents the global travel and tourism private sector, and Carnival Corporation, the world's largest cruise company. Hilton Worldwide Holdings and the U.S. Travel Association are supporting sponsors of the event. Moderators include:
              (EQNX::save_"-- ")Arnold Donald, president & CEO, Carnival Corporation
              (EQNX::save_"-- ")Gloria Guevara, president & CEO, WTTC
WHO (cont'd): Donald and Guevara will encourage straightforward, easy-to-understand and fact-based discussions sharing the latest insights on epidemiology, screening, testing and tracing, therapeutics, vaccines, practical prevention and mitigation practices and more. Panelists include (in alphabetical order):
              (EQNX::save_"-- ")Dr. Michael Diamond, M.D., Ph.D., the Herbert S. Gasser Professor of Medicine at Washington University. Dr. Diamond is recognized internationally for his work involving Zika, West Nile, chikungunya, and related emerging viruses.
              (EQNX::save_"-- ")Dr. Steven Gordon, M.D., chairman, department of infectious disease, Cleveland Clinic, Respiratory Institute and professor of medicine, The Lerner College of Medicine, Case Western University. Dr. Gordon has been focused on hospital infection prevention, including device-associated and opportunistic infections in immunocompromised patients.
              (EQNX::save_"-- ")Dr. Michael Lin, M.D., Ph.D. is Associate Professor of Neurobiology, Bioengineering, and Chemical and Systems Biology at Stanford University. A NIH Pioneer Award recipient, Dr. Lin develops protein-based tools for molecular imaging and control of gene and viral therapy.
              (EQNX::save_"-- ")Dr. William Morice, II, M.D., Ph.D., chair, department of laboratory medicine and pathology at Mayo Clinic, president, Mayo Clinic Laboratories, and professor of laboratory medicine and pathology. Dr. Morice is an expert in diagnostic testing serving in leadership roles for numerous boards and partnerships to enhance understanding of clinical diagnostics and test utilization.
              (EQNX::save_"-- ")Dr. Jewel Mullen, M.D., M.P.H., associate dean for health equity, University of Texas at Austin, Dell Medical School. Dr. Mullen is an internist, epidemiologist and public health physician leader and the former principal deputy assistant secretary for health in the U.S. Department of Health and Human Services (HHS).
              (EQNX::save_"-- ")Dr. Emil Christian Reisinger, director of the Department of Tropical Medicine and Infectious Diseases at the Department of Internal Medicine at the University of Rostock, Dean of the University and Member of the Board of the University Hospital Rostock.
              (EQNX::save_"-- ")Dr. Clare Rock, M.D., M.S., Associate Professor of Medicine, Associate Hospital Epidemiologist, Johns Hopkins University School of Medicine.  Dr. Rock has significant expertise in institutional COVID-19 support, including as Hospital Epidemiology and Infection Control COVID-19 Johns Hopkins Health System Incident Commander. Specific expertise and experience include COVID-19 testing strategies for the workplace, businesses, & community, return to work policies, return to business strategies, outbreak and cluster management, contact tracing, addressing COVID-19 vaccine hesitancy in the workplace and the community.
              (EQNX::save_"-- ")Dr. Stefano Vella, Adjunct Professor of Global Health at the Catholic University of Rome and a member of the Program Committee of Horizon Europe - Health Cluster, the Research Program of the European Commission. Dr. Vella specializes in infectious diseases and internal medicine and is a researcher in pathogenesis and therapy of viral infections. Specific research has been conducted by Dr. Vella on major pandemics, specifically on HIV/AIDS and Tuberculosis.
NEXT STEP:    Register for the event at:

View original content:

SOURCE Carnival Corporation & plc

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.